Introduzione

Switzerland is not part of the European Union (EU) or the European Economic Area (EEA) and regulations such as the EU Clinical Trials Regulation - Reg. (EU) No. 536/2014 do not apply here. However, Switzerland tries to keep up the alignment with the EU and introduced some of these principles in the national legislation in June 2024.
This comprehensive course will guide you through these legislative updates, effective starting from November 1st, 2024, and their practical implications for clinical trial applications. The new requirements bring more stringent standards, impacting both ongoing and future clinical trials in Switzerland.
If you are conducting or planning to conduct clinical trials in Switzerland, this course will equip you with the knowledge you need to confidently navigate these upcoming changes.

  • Background and rationale for clinical trial legislative changes
  • Overview of changes in the Swiss Human Research Act and related Ordinances and comparison with EU legislation
  • Impact on submission processes, tools and templates
  • Discussion and case studies

This course is aimed at professionals who are involved in submitting and/or conducting clinical trials in Switzerland, such as:

– Regulatory specialists
– Clinical Trial Submission specialists
– Clinical Operations professionals

Participant experience: An understanding of the principles of clinical research

This course paints a comprehensive picture of the changes brought to the Swiss clinical trials regulations, the submission process and forms, and how these changes compare to the established EU legislative framework (EU CTR, Reg. (EU) No. 536/2014), using practical exercises and case studies.

Docente/i
Ruxandra Popescu
Info

Ruxandra Popescu

Consultant at RPRC – Ruxandra Popescu Regulatory Consulting

Ruxandra is a pharmacist with over 9 years of experience in Regulatory Affairs and an EMA-certified CTIS Sponsor Master Trainer. In her role as freelance regulatory consultant, she helps clinical trial sponsors navigate the complexities of clinical trial regulations, providing targeted submission strategy advice, implementation support and training on the EU Clinical Trials Regulation (EU CTR, Reg. (EU) No. 536/2014) and the CTIS portal. Ruxandra is also the Head of Regulatory Affairs and Quality Assurance at Recolony, a Swiss start-up and spin-off from the University of Zurich, where she builds and implements the regulatory strategy for developing new anticancer therapies and is responsible for the Quality Management System of the company. Prior to this, Ruxandra held the role of Regulatory Affairs Manager, Europe at Travere Therapeutics in Switzerland, coordinating the internal EU CTR implementation and advising on clinical trial submission aspects. Before joining Travere, Ruxandra worked as Senior Regulatory Scientist at Voisin Consulting Life Sciences, where she was leading clinical trial submissions in Switzerland and other European and non-European countries, also preparing and delivering trainings on the EU CTR and CTIS. During her tenure at the European Medicines Agency, Ruxandra has contributed to the development of the CTIS portal, also being involved in user testing.


Online Training – 1 module

10 December 2024 from h. 09:30 AM to h. 12:30 PM CET

Few days before the online training you will receive all details about the connection.

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.

Early Bird: € 390,00 * until 19/11/2024

Ordinary: € 510,00 *

Freelance – Individual – Academy – Public Administration**: € 310,00 *

* for Italian companies: +22% VAT

** Early Bird discount not applicable to Freelance – Individual – Academy – Public Administration fee

The fee includes: tuitions, organizational office assistance, teaching materials and attendance certificate that will be sent after the training via e-mail.

Registrati
Ordinaria
Acquistabile fino al 09/12/2024
510,00
Freelance - Privato - Accademia - Pubblica Amministrazione
Acquistabile fino al 09/12/2024
310,00
Svuota

Roberta Alberti
Roberta Alberti
Events & Training Manager
Versione Stampabile
Cosa saprai fare dopo il corso
Risultato atteso
Understand the key updates to the Swiss clinical trial legislation and associated submission tools and templates
Risultato atteso
Apply the changes to prepare compliant submission packages for clinical trials conducted in Switzerland
Risultato atteso
Gain clarity on the differences and similarities between the Swiss clinical trial legislation and the EU Clinical Trials Regulation (EU CTR, Reg. (EU) No. 536/2014)
Risultato atteso
Integrate the Swiss regulatory perspective in a robust clinical trial regulatory strategy for conducting pan-European clinical trials